Alexandria logo

Alexandria

North America, California, United States, San Francisco

Description

Alexandria Venture Investments is the dedicated strategic venture capital arm of Alexandria Real Estate Equities, Inc. (NYSE: ARE), a leading real estate investment trust focused on collaborative life science, agrifoodtech, and technology campuses. Established in 1996, Alexandria Venture Investments leverages its parent company's deep industry expertise and extensive network to identify and support groundbreaking companies across various stages, from seed to late-stage. Their investment strategy is highly synergistic, aiming to foster innovation within the sectors where Alexandria Real Estate Equities operates, often providing portfolio companies with access to state-of-the-art laboratory and office space, as well as strategic partnerships and resources.

The firm's unique value proposition extends beyond capital, offering a comprehensive ecosystem designed to accelerate the growth and success of its portfolio companies. This includes facilitating connections with key opinion leaders, potential collaborators, and strategic partners within the life science and technology communities. Alexandria Venture Investments is committed to building long-term relationships, acting as a supportive partner throughout a company's lifecycle, from initial concept to commercialization and beyond.

Alexandria Venture Investments boasts a substantial and diverse portfolio, reflecting its long-standing commitment to critical innovation sectors. As of December 31, 2023, the firm had invested in over 700 companies, demonstrating a broad reach across the innovation landscape. Their total portfolio investments amounted to approximately $2.6 billion, underscoring their significant financial commitment to fostering scientific and technological advancements. This extensive track record positions Alexandria Venture Investments as a pivotal player in the venture capital ecosystem, particularly for companies seeking not just funding, but also strategic real estate solutions and a robust support network.

Investor Profile

Alexandria has backed more than 41 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 2% of its total and boasts 20 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series B, Series C rounds (top funding stages).
  • Majority of deals are located in United States, France.
  • Strong thematic focus on Biotechnology, Health Care, Therapeutics.
  • Typical check size: $1M – $25M.

Stage Focus

  • Series A (39%)
  • Series B (37%)
  • Series C (12%)
  • Seed (5%)
  • Convertible Note (2%)
  • Private Equity (2%)
  • Series Unknown (2%)

Country Focus

  • United States (98%)
  • France (2%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Life Science
  • Pharmaceutical
  • Medical
  • Genetics
  • Biopharma
  • Artificial Intelligence (Ai)
  • Agtech
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Alexandria frequently co-invest with?

EcoR1 Capital
North America, California, United States, San Francisco
Co-Investments: 5
Pfizer Venture Investments
North America, New York, United States, New York
Co-Investments: 7
Bay City Capital
North America, California, United States, San Francisco
Co-Investments: 4
Lundbeckfonden Ventures
Europe, Hovedstaden, Denmark, Copenhagen
Co-Investments: 4
Casdin Capital
North America, New York, United States, New York
Co-Investments: 5
Celgene
North America, New Jersey, United States, Summit
Co-Investments: 4
Polaris Partners
North America, Massachusetts, United States, Boston
Co-Investments: 6
Flagship Pioneering
North America, Massachusetts, United States, Cambridge
Co-Investments: 5
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 7
Fidelity
North America, Massachusetts, United States, Boston
Co-Investments: 4

Which angels does Alexandria often collaborate with?

IJ
North America, California, United States, La Jolla
Shared Deals: 1
HT
Europe, Noord-Brabant, The Netherlands, Tilburg
Shared Deals: 1
JD
North America, California, United States, San Francisco
Shared Deals: 1
BN
North America, Massachusetts, United States, Boston
Shared Deals: 1
Shared Deals: 1
AH
North America, Oregon, United States, Bend
Shared Deals: 1
AE
North America, New York, United States, New York
Shared Deals: 1
SM
Europe, England, United Kingdom, London
Shared Deals: 1

What are some of recent deals done by Alexandria?

Tiamat Sciences

Durham, North Carolina, United States

Tiamat Sciences makes plant-based growth factors & proteins for cell-culture

AgTechBiotechnologyFood and BeverageMedical
SeedMar 9, 2023
Amount Raised: $2,000,000
ImCheck Therapeutics

Marseille, Provence-Alpes-Cote d'Azur, France

ImCheck Therapeutics is a developing novel therapeutics that target members of the butyrophilin (BTN) super-family of checkpoint molecules.

BiopharmaBiotechnologyHealth CareLife ScienceTherapeutics
Series CJun 13, 2022
Amount Raised: $99,985,627
BIOMILQ

Durham, North Carolina, United States

Unlocking human potential with breakthrough mammary biotechnology.

AgTechBabyBiotechnologyFood and Beverage
Series AOct 20, 2021
Amount Raised: $21,000,000
Kojin Therapeutics

Cambridge, Massachusetts, United States

Kojin is a biopharmaceutical company that develops new targeted therapeutics based on cell state and ferroptosis biology.

BiopharmaBiotechnologyHealth CareLife ScienceMedical
Series AJun 9, 2021
Amount Raised: $60,000,000
Think Brilliant Media Studios

Portland, Oregon, United States

Think Brilliant Media Studios specializes in high performance web development and custom media solutions across multiple platforms.

SoftwareWeb Development
Private EquityAug 13, 2020
Amount Raised: $7,000,000
TARA Biosystems

New York, New York, United States

TARA Biosystems Harnessing Human Biology + Data to Transform Cardiac Drug Discovery

BiotechnologyMedical
Series AJun 23, 2020
Amount Raised: $10,000,000
Crop Enhancement

San Jose, California, United States

Crop Enhancement develop sustainable agrochemical formulations that employ environmentally friendly chemistry to improve crop yields.

AgricultureChemicalFarming
Series BApr 14, 2020
Amount Raised: $8,000,000
Triplet Therapeutics

Cambridge, Massachusetts, United States

Triplet is developing transformative therapies that treat repeat expansion disorders at their source.

BiotechnologyHealth Care
Series ADec 17, 2019
Amount Raised: $49,000,000
Inhibrx

La Jolla, California, United States

Inhibrx is a clinical-stage biotechnology company that focuses on developing a broad pipeline of biologic therapeutic candidates.

BiotechnologyLife ScienceTherapeutics
Convertible NoteMay 21, 2019
Amount Raised: $40,000,000
Vividion Therapeutics

San Diego, California, United States

Vividion is a developer of a novel drug discovery platform designed to offer transformative treatments to patients with serious illnesses.

BiotechnologyHealth CareTherapeutics
Series BApr 30, 2019
Amount Raised: $82,000,000